國家衛生研究院 NHRI:Items for Author

Year

Loading year class tree, please wait....

Items for Author "Tsai, KK"

Return to Browse by Author

Showing 29 items.

Collection	Date	Title	Relation
[陳立宗] 期刊論文	2020-01	A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study	-
[褚志斌] 期刊論文	2024-03	ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells	-
[褚志斌] 期刊論文	2022-05-26	Screening of organoids derived from patients with breast cancer implicates the repressor NCOR2 in cytotoxic stress response and antitumor immunity	-
[褚志斌] 期刊論文	2022-03	Inhibition of KDM4C/c-Myc/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolism	-
[褚志斌] 期刊論文	2019-11-13	Histone demethylase KDM4C stimulates the proliferation of prostate cancer cells via activation of AKT and c-Myc	-
[蔡坤志] 期刊論文	2023-09-15	Oncogenic ASPM is a regulatory hub of developmental and stemness signaling in cancers	-
[蔡坤志] 期刊論文	2023-03	ASPM activates Hedgehog and Wnt signaling to promote small cell lung cancer stemness and progression	-
[蔡坤志] 期刊論文	2021-06-22	A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells [Erratum:Frontiers in Oncology. 2021 May 31;11:Article number 638311.]	-
[蔡坤志] 期刊論文	2021-05-31	A novel invadopodia-specific marker for invasive and pro-metastatic cancer stem cells	-
[蔡坤志] 期刊論文	2021-05	A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer	-
[蔡坤志] 期刊論文	2021-05	A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer[Erratum:Gastric Cancer. 2021 May;24(3):624-639.]	-
[蔡坤志] 期刊論文	2020-03-10	Dishevelled 1-regulated superpotent cancer stem cells mediate wnt heterogeneity and tumor progression in hepatocellular carcinoma	-
[蔡坤志] 期刊論文	2019-12	The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis	-
[蔡坤志] 期刊論文	2019-07	Targeting the interplay between cancer fibroblasts, mesenchymal stem cells, and cancer stem cells in desmoplastic cancers	-
[蔡坤志] 期刊論文	2019-05-17	Next viable routes to targeting pancreatic cancer stemness: Learning from clinical setbacks	-
[蔡坤志] 期刊論文	2019-02	ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling	-
[蔡坤志] 期刊論文	2019-02	ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling [Erratum: Oncogene. 2019 Feb;38(8):1340-1353.]	-
[蔡坤志] 期刊論文	2017-11	Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma	-
[蔡坤志] 期刊論文	2016-12	Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells	-
[蔡坤志] 期刊論文	2015-09	Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers	-
[蔡坤志] 期刊論文	2013-11	A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression	-
[蔡坤志] 會議論文/會議摘要	2018-12	ACTL6a promotes metastasis and predicts poor prognosis of prostate cancer via regulation of YAP and cancer stemness	-
[蔡坤志] 會議論文/會議摘要	2018-11	Targeting PTX3 can prevent drug-resistant cancer progression	-
[蔡坤志] 會議論文/會議摘要	2016-12	NCoR2 mediates death-resistance and mechano-regulation of glioblastoma multiforme	-
[蔡坤志] 會議論文/會議摘要	2015-11	Proteomics profiling of epigenetic proteins during acinar morphogenesis to identify prostate cancer prognostic markers	-
[蔡坤志] 會議論文/會議摘要	2012-12	A molecular signature of tubulogenesis in pancreatic cancer and oncogenic role of ASPM	-
[江士昇] 期刊論文	2013-02	Molecular profiling of prostatic acinar morphogenesis identifies PDCD4 and KLF6 as tissue architecture-specific prognostic markers in prostate cancer	-
[姜乃榕] 會議論文/會議摘要	2018-10	Multicenter, phase II trial of biweekly S-1, leucovorin (LV), oxaliplatin and gemcitabine (SLOG) in metastatic pancreatic adenocarcinoma (mPDAC): Final report of TCOG T1211 study	-
[姜乃榕] 會議論文/會議摘要	2016-02	Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC)	-

Loading...

Category

Year

Items for Author "Tsai, KK"